Biomerica (BMRA) Capital Expenditures Growth (5y) (2015 - 2024)
Biomerica (BMRA) Capital Expenditures Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -3.17% |
| Nov 30, 2023 | -16.74% |
| Aug 31, 2023 | -11.22% |
| Feb 28, 2023 | -22.44% |
| Nov 30, 2022 | -6.14% |
| Aug 31, 2022 | 11.23% |
| May 31, 2022 | 149.68% |
| Feb 28, 2022 | -27.21% |
| May 31, 2021 | 6.18% |
| Feb 28, 2021 | 1.62% |
| Nov 30, 2020 | -0.57% |
| Aug 31, 2020 | 47.45% |
| May 31, 2020 | 26.08% |
| Feb 29, 2020 | 539.56% |
| Nov 30, 2019 | -3.57% |
| Aug 31, 2019 | -9.99% |
| May 31, 2019 | 7.25% |
| Feb 28, 2019 | -9.93% |
| Nov 30, 2018 | -27.55% |
| Aug 31, 2018 | 34.25% |